BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b
244 results:

  • 1. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
    Pallocca M; Molineris I; Berrino E; Marcozzi B; Betti M; Levati L; D'Atri S; Menin C; Madonna G; Ghiorzo P; Bulgarelli J; Ferraresi V; Venesio T; Rodolfo M; Rivoltini L; Lanfrancone L; Ascierto PA; Mazzarella L; Pelicci PG; De Maria R; Ciliberto G; Medico E; Russo G
    J Transl Med; 2024 Jan; 22(1):29. PubMed ID: 38184610
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
    Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
    Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease.
    Dieudonné Y; Silvestrini MA; Dossier A; Meignin V; Jouenne F; Mahévas T; Bouaziz JD; Jackson MA; Mordant P; Poirot J; Onodi F; Calvani J; Hourseau M; Evrard D; Berisha M; Perrin F; Danel C; Borie R; Galicier L; Mourah S; Bengoufa D; Oksenhendler E; Grootenboer-Mignot S; Boutboul D
    Br J Haematol; 2023 Jul; 202(2):267-278. PubMed ID: 37221131
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High-Grade sarcomas with Myogenic Differentiation Harboring Hotspot pdgfrb Mutations.
    Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
    Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An integrative approach for exploring the nature of fibroepithelial neoplasms.
    Yun J; Heo W; Lee ES; Na D; Kang W; Kang J; Chae J; Lee D; Lee W; Hwang J; Yoo TK; Hong BS; Son HY; Noh DY; Lee C; Moon HG; Kim JI
    Br J Cancer; 2023 Feb; 128(4):626-637. PubMed ID: 36522480
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone sarcomas.
    Albarrán V; Villamayor ML; Chamorro J; Rosero DI; Pozas J; San Román M; Calvo JC; Pérez de Aguado P; Moreno J; Guerrero P; González C; García de Quevedo C; Álvarez-Ballesteros P; Vaz MÁ
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430263
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity.
    Dermawan JK; DiNapoli SE; Sukhadia P; Mullaney KA; Gladdy R; Healey JH; Agaimy A; Cleven AH; Suurmeijer AJH; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2023 Apr; 62(4):191-201. PubMed ID: 36344258
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Label-Free Direct Mass Spectrometry Analysis of the Bystander Effects Induced in Chondrocytes by Chondrosarcoma Cells Irradiated with X-rays and Carbon Ions.
    Gilbert A; Payet V; Bernay B; Chartier-Garcia E; Testard I; Candéias SM; Chevalier F
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):277. PubMed ID: 36224025
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A rapidly growing cutaneous malignant glomus tumor with a CCND3 mutation.
    Kitz R; Leung O; Royer M
    J Cutan Pathol; 2023 Feb; 50(2):113-117. PubMed ID: 36059094
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of Potential Drug Therapy for Dermatofibrosarcoma Protuberans with Bioinformatics and Deep Learning Technology.
    Liu M; Yang F; Xu Y
    Curr Comput Aided Drug Des; 2022; 18(5):393-405. PubMed ID: 35975851
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Ripretinib in advanced gastrointestinal stromal tumors: an overview of current evidence and drug approval.
    Goggin C; Stansfeld A; Mahalingam P; Thway K; Smith MJ; Huang P; Jones RL; Napolitano A
    Future Oncol; 2022 Aug; 18(26):2967-2978. PubMed ID: 35880452
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeting Podoplanin for the Treatment of Osteosarcoma.
    Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
    Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (pdgfr) Inhibitors for the Treatment of Osteosarcoma.
    Chen X; Liu L; Liu P; Chen Y; Lin D; Yan H; Yan Q; Wang Y; Qiu Y; Fang B; Huang H; Qian J; Zhao Y; Du Z; Zhang Q; Li X; Zheng X; Liu Z
    J Med Chem; 2022 Apr; 65(7):5374-5391. PubMed ID: 35239349
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
    Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H
    Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Role of Immunohistochemistry in the Differential Diagnosis of Pediatric Renal Tumors: Expression of Cyclin D1, Beta-Catenin , pdgfr-Alpha, and PTEN.
    Kepil N; Batur Ş; Kain ZE; Özcan G; Emre Ş; Özcan R; Celkan TT; Çomunoğlu N
    Turk Patoloji Derg; 2022; 38(2):83-89. PubMed ID: 35147974
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma.
    Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
    Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Surgical and interdisciplinary treatment of gastrointestinal stromal tumors].
    Schmidt T; Ghadimi M; Fuchs HF; Bruns CJ
    Chirurg; 2022 Jan; 93(1):27-33. PubMed ID: 34709443
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Myeloid/lymphoid neoplasms with FLT3 rearrangement.
    Tang G; Tam W; Short NJ; Bose P; Wu D; Hurwitz SN; Bagg A; Rogers HJ; Hsi ED; Quesada AE; Wang W; Miranda RN; Bueso-Ramos CE; Medeiros LJ; Nardi V; Hasserjian RP; Arber DA; Orazi A; Foucar K; Wang SA
    Mod Pathol; 2021 Sep; 34(9):1673-1685. PubMed ID: 33990705
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
    Brahmi M; Lesluyes T; Dufresne A; Toulmonde M; Italiano A; Mir O; Le Cesne A; Valentin T; Chevreau C; Bonvalot S; Penel N; Coindre JM; Le Guellec S; Le Loarer F; Karanian M; Blay JY; Chibon F
    ESMO Open; 2021 Feb; 6(1):100037. PubMed ID: 33524869
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Primary extraskeletal osteosarcoma: a clinicopathological study of ten cases].
    Huang HJ; Jiang QJ; Fan DG; Chen XY; Zhong DR
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):44-48. PubMed ID: 33396986
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 13.